Abnormal cervical screening / cervical dysplasia / abnormal cervix

Cat 1 · 30 days

appointment within 30 calendar days. - Invasive cancer (squamous, glandular, other). For optimum care, patient should be seen by gynaecological oncology (National guidelines suggests being seen at the earliest opportunity for urgent evaluation) - LBC of PHSIL/HSIL - Positive HPV 16/18 (LBC not required prior to referral; review ideally within 8 weeks) and - Unknown cytology - Unsatisfactory LBC - Previous treatment for PHSIL/HSIL (ideally reviewed within 8 weeks) - Past history of positive HPV 16/18 (ideally reviewed within 8 weeks) - Glandular lesions - AIS or possible high grade glandular lesion - Any atypical glandular cells/endocervical cells of undetermined significance

Cat 2 · 90 days

appointment within 90 calendar days. - Positive HPV 16/18 and - normal LBC - PLSIL/LSIL - Positive HPV non 16/18 and - Persistant positive non 16/18 HPV or HPV other - on 3 consecutive yearly test or - in a person who is: - two or more years overdue for screening at the time of the initial screen - identifies as Aboriginal or Torres Strait Islander - aged 50-69 years - women aged 70+ - immune deficient women - women currently undergoing Test of Cure following treatment of histological HSIL - History of diethylstilboestrol (DES) exposure in utero regardless of HPV status or LBC test - Abnormal appearing cervix with normal cervical screening - Recurrent post-coital bleeding in pre-menopausal woman after STI excluded/treated – gynaecological assessment recommended - Any episode of unexplained vaginal bleeding (including post-coital) in a post-menopausal woman - Unexplained persistent unusual vaginal discharge, especially if offensive and blood stained and after STI excluded/treated - Any abnormal result and past history of excisional treatment of AIS

Cat 3 · 365 days

appointment within 365 calendar days. - No category 3 criteria